# Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers

> **NCT00875017** · PHASE1 · COMPLETED · sponsor: **Shire** · enrollment: 31 (actual)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** Lanthanum Carbonate
- **DRUG:** Sevelamer

## Key facts

- **NCT ID:** NCT00875017
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-20
- **Primary completion:** 2009-06-16
- **Final completion:** 2009-06-16
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2021-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00875017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00875017, "Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00875017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*